Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.060
+0.477 (81.82%)
At close: Oct 29, 2025, 4:00 PM EDT
0.8800
-0.1800 (-16.98%)
After-hours: Oct 29, 2025, 6:54 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $8.86 million as of October 29, 2025. Its market cap has decreased by -22.70% in one year.
Market Cap
8.86M
Enterprise Value
2.90M
1-Year Change
-22.70%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $8.86M, an increase of 78.32%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 8.90M | -19.62% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |